Differential regulation and properties of angiopoietin-like proteins 3 and 4

Journal of Lipid Research

Volumn 46, Issue 7, 2005, Pages 1484-1490

  Ge, Hongfei ^a,b   Cha, Ji Young ^a,b   Gopal, Harini ^a,b   Harp, Christopher ^a,b   Yu, Xinxin ^a,b   Repa, Joyce J ^a,b   Li, Cai ^a,b,c  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Angptl3; Angptl4; Gel filtration; Liver X receptor; LPL; Nutritional status; Peroxisome proliferator activated receptor

Indexed keywords

ANGIOPOIETIN LIKE PROTEIN 3; ANGIOPOIETIN LIKE PROTEIN 4; CELL NUCLEUS RECEPTOR; GROWTH FACTOR; LIGAND; LIVER X RECEPTOR; OLIGOMER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGPTL3 PROTEIN, MOUSE; ANGPTL4 PROTEIN, MOUSE; FENOFIBRATE; GW0742; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PLASMA PROTEIN; SIGNAL PEPTIDE; THIAZOLE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISULFIDE BOND; GENE TARGETING; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; LIVER; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUTRITIONAL STATUS; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; REGULATORY MECHANISM; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG POTENTIATION; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; PROTEIN QUATERNARY STRUCTURE;

ANIMALS; BLOOD PROTEINS; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEIN LIPASE; MALE; MICE; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; PROCETOFEN; PROTEIN STRUCTURE, QUATERNARY; THIAZOLES; THIAZOLIDINEDIONES;

EID: 24744459686     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500005-JLR200     Document Type: Article

References (26)

1. Koishi, R., Y. Ando, M. Ono, M. Shimamura, H. Yasumo, T. Fujiwara, H. Horikoshi, and H. Furukawa. 2002. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30: 151-157.
2. Shimizugawa, T., M. Ono, M. Shimamura, K. Yoshida, Y. Ando, R. Koishi, K. Ueda, T. Inaba, H. Minekura, T. Kohama, et al. 2002. Angptl3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277: 33742-33748.
3. Yoshida, K., T. Shimizugawa, M. Ono, and H. Furukawa. 2002. Angiopoietin- like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43: 1770-1772.
4. Ge, H., G. Yang, X. Yu, T. Pourbahrami, and C. Li. 2004. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J. Lipid Res. 45: 2071-2079.
5. Inaba, T., M. Matsuda, M. Shimamura, N. Takei, N. Terasaka, Y. Ando, H. Yasumo, R. Koishi, M. Makishima, and I. Shimomura. 2003. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver x receptor. J. Biol. Chem. 278: 21344-21351.
6. Kaplan, R., T. Zhang, M. Hernandez, F. X. Gan, S. D. Wright, M. G. Waters, and T. Q. Cai. 2003. Regulation of the angiopoietin-like protein 3 gene by lxr. J. Lipid Res. 44: 136-143.
7. Kersten, S., S. Mandard, N. S. Tan, P. Escher, D. Metzger, P. Chambon, F. J. Gonzalez, B. Desvergne, and W. Wahli. 2000. Characterization of the fasting-induced adipose factor fiaf, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275:28488-28493.
8. Yoon, J. C., T. W. Chickering, E. D. Rosen, B. Dussault, Y. Qin, A. Soukas, J. M. Friedman, W. E. Holmes, and B. M. Spiegelman. 2000. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 20: 5343-5349.
9. Akiyama, T. E., G. Lambert, C. J. Nicol, K. Matsusue, J. M. Peters, H. B. Brewer, Jr., and F. J. Gonzalez. 2004. Peroxisome proliferator-activated receptor {beta}/{delta} regulates very low density lipoprotein production and catabolism in mice on a Western diet. J. Biol. Chem. 279: 20874-20881.
10. Schmuth, M., C. M. Haqq, W. J. Cairns, J. C. Holder, S. Dorsam, S. Chang, P. Lau, A. J. Fowler, G. Chuang, A. H. Moser, et al. 2004. Peroxisome proliferator-activated receptor (ppar)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J. Invest. Dermatol. 122: 971-983.
11. Inukai, K., Y. Nakashima, M. Watanabe, S. Kurihara, T. Awata, H. Katagiri, Y. Oka, and S. Katayama. 2004. Angptl3 is increased in both insulin-deficient and -resistant diabetic states. Biochem. Biophys. Res. Commun. 317: 1075-1079.
12. Shimamura, M., M. Matsuda, Y. Ando, R. Koishi, H. Yasumo, H. Furukawa, and I. Shimomura. 2004. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem. Biophys. Res. Commun. 322: 1080-1085.
13. Kim, I., H. G. Kim, H. Kim, H. H. Kim, S. K. Park, C. S. Uhm, Z. H. Lee, and G. Y. Koh. 2000. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 346: 603-610.
14. Backhed, F., H. Ding, T. Wang, L. V. Hooper, G. Y. Koh, A. Nagy, C. F. Semenkovich, and J. I. Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101: 15718-15723.
15. Wiesner, G., B. A. Morash, E. Ur, and M. Wilkinson. 2004. Food restriction regulates adipose-specific cytokines in pituitary gland but not in hypothalamus. J. Endocrinol. 180: R1-R6.
16. Belanger, A. J., H. Lu, T. Date, L. X. Liu, K. A. Vincent, G. Y. Akita, S. H. Cheng, R. J. Gregory, and C. Jiang. 2002. Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (pgar) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J. Mol. Cell. Cardiol. 34: 765-774.
17. Yoshida, K., M. Ono, R. Koishi, and H. Furukawa. 2004. Characterization of the 5′ regulatory region of the mouse angiopoietin-like protein 4. Vet. Res. Commun. 28: 299-305.
18. Mandard, S., F. Zandbergen, N. S. Tan, P. Escher, D. Patsouris, W. Koenig, R. Kleemann, A. Bakker, F. Veenman, W. Wahli, et al. 2004. The direct ppar target fiaf/pgar/angptl4 is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 279: 34411-34420.
19. Yu, X., S. C. Burgess, H. Ge, K. K. Wong, R. H. Nassem, D. J. Garry, A. D. Sherry, C. R. Malloy, J. P. Berger, and C. Li. 2005. Inhibition of cardiac lipoprotein utilization by transgenic over-expression of angptl4 in the heart. Proc. Natl. Acad. Sci. U.S.A. 102: 1767-1772.
20. Huang, L., Z. Wang, and C. Li. 2001. Modulation of circulating leptin levels by its soluble receptor. J. Biol. Chem. 276: 6343-6349.
21. Kurrasch, D. M., J. Huang, T. M. Wilkie, and J. J. Repa. 2004. Quantitative real-time polymerase chain reaction measurement of regulators of g-protein signaling mrna levels in mouse tissues. Methods Enzymol. 389: 3-15.
22. Schlaepfer, I. R., L. K. Pulawa, L. D. Ferreira, D. E. James, W. H. Capell, and R. H. Eckel. 2003. Increased expression of the snare accessory protein munc18c in lipid-mediated insulin resistance. J. Lipid Res. 44: 1174-1181.
23. Ward, N. L., and D. J. Dumont. 2002. The angiopoietins and tie2/tek: Adding to the complexity of cardiovascular development. Semin. Cell Dev. Biol. 13: 19-27.
24. Ge, H., G. Yang, L. Huang, D. L. Motola, T. Pourbahrami, and C. Li. 2004. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 279: 2038-2045.
25. Kratky, D., R. Zimmermann, E. M. Wagner, J. G. Strauss, W. Jin, G. M. Kostner, G. Haemmerle, D. J. Rader, and R. Zechner. 2005. Endothelial lipase provides an alternative pathway for ffa uptake in lipoprotein lipase-deficient mouse adipose tissue. J. Clin. Invest. 115: 161-167.
26. Jin, W., J. S. Millar, U. Broedl, J. M. Glick, and D. J. Rader. 2003. Inhibition of endothelial lipase causes increased hdl cholesterol levels in vivo. J. Clin. Invest. 111: 357-362.